Rubric Capital Management LP 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL | Rubric Capital Management LP | 1,333,893 3.050% | -601,464 (-31.08%) | Filing |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | Rubric Capital Management LP | 1,935,357 5.350% | 99,970 (+5.45%) | Filing |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | Rubric Capital Management LP | 1,835,387 5.970% | 1,835,387 (New Position) | Filing |